Position in NTRA
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$426,774
-$69,433 QoQ
Shares Held
2,134
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JOURNEY STRATEGIC WEALTH LLC holds $4,914,663 across 7 Diagnostics & Research names. NTRA ranks #3 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,807 | $1,871,252 | |
| 2 | DHR |
Danaher Corp /De/
|
7,674 | $1,454,986 | |
| 3 | NTRA |
Natera, Inc.
This page
|
2,134 | $426,774 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
823 | $395,195 | |
| 5 | ILMN |
Illumina, Inc.
|
2,381 | $293,479 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
445 | $250,036 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,956 | $222,941 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $426,774 | 2,134 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $496,207 | 2,166 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $316,142 | 1,964 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $290,404 | 1,719 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||